Medicine News and Research

RSS

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

To coincide with World Alzheimer’s Month, EIT Health, an EU-backed network of best-in-class health innovators, has highlighted the urgent need to focus on implementing bolder approaches to the treatment of Alzheimer’s Disease post-pandemic.

20 Sep 2021

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine.

20 Sep 2021

Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma

An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center.

20 Sep 2021

Commonly prescribed cholesterol-lowering drugs could be effective in treating ulcerative colitis

There may be good news for the nearly 1 million people battling ulcerative colitis, a type of inflammatory bowel condition with no real cure: Statins, a commonly prescribed cholesterol-lowering drug, seem to be an effective, if unexpected, treatment for the condition, according to a new Stanford Medicine study.

20 Sep 2021

New data shows benefit of drug combination for metastatic castration resistant prostate cancer

New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration resistant prostate cancer (mCRPC).

18 Sep 2021

R37 MERIT Award supports innovative ovarian cancer research

One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors (short for poly adenosine diphosphate-ribose polymerase). PARP inhibitors are a type of cancer drug that blocks the PARP enzyme from helping to repair DNA damage in cancer cells.

18 Sep 2021

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.

18 Sep 2021

Higher white matter extracellular free-water related to cognitive dysfunction in lupus patients

Systemic lupus erythematosus (SLE) is an autoimmune disease in which the immune system attacks the body's own tissues, causing widespread inflammation and damage in the affected organs.

18 Sep 2021

Increased presence of certain bacteria in the gut may indicate colon cancer risk

A study published today in the journal Cell Host & Microbe reported that the increased presence of certain bacteria in a gut biome indicates a greater likelihood that colon polyps will become cancerous.

18 Sep 2021

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.

18 Sep 2021

Study of internet-delivered trauma-focused CBT shows promising results

Traumatic experiences such as assault or a road accident can give rise to nightmares, flashbacks and other mental reactions, and accessible therapy is needed to prevent exacerbation of the problems.

18 Sep 2021

UW Medicine enrolls volunteers for COVID-19 booster vaccine trial

Researchers at the University of Washington School of Medicine are enrolling volunteers for a COVID-19 booster vaccine trial.

18 Sep 2021

Thousands of vulnerable hospital patients set to benefit from new COVID-19 treatment

Thousands of vulnerable NHS patients in hospital due to COVID-19 are set to benefit from a ground-breaking new antibody treatment, the government has announced today (17 September 2021).

18 Sep 2021

Study finds risk factors for early COPD among Hispanics and Latinos in the U.S.

Chronic obstructive pulmonary disease (COPD) is a progressive disorder that is often not diagnosed until a patient is over 60 years old and has substantial airflow obstruction. At this stage, it can be difficult to manage and treat the condition. To identify those at risk and intervene earlier, several studies have examined risk factors for COPD.

17 Sep 2021

Researchers report six stages of engagement in treatment of ADHD

Six stages of engagement in treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) have been reported by researchers at Boston Medical Center based on a diverse study, inclusive of parents of predominantly racial and ethnic minority children with ADHD.

17 Sep 2021

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

A team of international scientists and clinical experts have unraveled a new cell type in human skin that contributes to inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis (PSO). Their study findings were published in the Journal of Experimental Medicine in September 2021.

17 Sep 2021

Scientists examine kids’ unique immune systems as more fall victim to covid

Eighteen months into the covid-19 pandemic, with the delta variant fueling a massive resurgence of disease, many hospitals are hitting a heartbreaking new low. They're now losing babies to the coronavirus.

17 Sep 2021

Covid-overwhelmed hospitals postpone cancer care and other treatment

It's a bad time to get sick in Oregon. That's the message from some doctors, as hospitals fill up with covid-19 patients and other medical conditions go untreated.

17 Sep 2021

Owlstone Medical appoints Mark Capone to board of directors

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.

From Owlstone Medical Ltd 17 Sep 2021

Shared language must be clear enough to help people working together in public health, experts say

A large group of family medicine researchers, educators and clinicians propose a framework of definitions to clarify the similarities, differences and relationships between common terms used by those involved in population health, community health and public health. They write that shared language must be clear enough to help and not hinder people working together as they come to a mutual understanding of roles, responsibilities and actions in their joint work.

17 Sep 2021

Medicine News and Research

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma

Commonly prescribed cholesterol-lowering drugs could be effective in treating ulcerative colitis

New data shows benefit of drug combination for metastatic castration resistant prostate cancer

R37 MERIT Award supports innovative ovarian cancer research

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

Higher white matter extracellular free-water related to cognitive dysfunction in lupus patients

Increased presence of certain bacteria in the gut may indicate colon cancer risk

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

Study of internet-delivered trauma-focused CBT shows promising results

UW Medicine enrolls volunteers for COVID-19 booster vaccine trial

Thousands of vulnerable hospital patients set to benefit from new COVID-19 treatment

Study finds risk factors for early COPD among Hispanics and Latinos in the U.S.

Researchers report six stages of engagement in treatment of ADHD

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

Scientists examine kids’ unique immune systems as more fall victim to covid

Covid-overwhelmed hospitals postpone cancer care and other treatment

Owlstone Medical appoints Mark Capone to board of directors

Shared language must be clear enough to help people working together in public health, experts say

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News